Literature DB >> 688696

Interferon production and lymphocyte stimulation in human leucocyte cultures stimulated by Corynebacterium parvum.

H M Hirt, M Schwenteck, H Becker, H Kirchner.   

Abstract

Killed C. parvum organisms stimulated a lymphoproliferative response in human peripheral leucocyte cultures of both adult and cord blood origin. They also induced high titres of interferon in cultures of adult leucocytes, but there was no correlation between the degree of lymphocyte stimulation and of interferon production. A considerable variability between donors was seen in both assays. The amount of interferon produced in C. parvum-stimulated cultures was considerably higher than that stimulated by the T-cell mitogens PHA and Con A and that induced by LPS. The anti-viral protein induced by C. parvum fulfilled the criteria of interferon and appeared to represent type II interferon.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 688696      PMCID: PMC1541340     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  [STIMULATION OF THE PHAGOCYTIC ACTIVITY OF THE RETICULOENDOTHELIAL SYSTEM BY CORYNEBACTERIUM PARVUM].

Authors:  B N HALPERN; A R PREVOT; G BIOZZI; C STIFFEL; D MOUTON; J C MORARD; Y BOUTHILLIER; C DECREUSEFOND
Journal:  J Reticuloendothel Soc       Date:  1964-01

2.  Effect of A. laidlawii on murine and human lymphocyte cultures.

Authors:  H Kirchner; H Brunner; H Rühl
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

3.  Production of an antiviral factor by murine spleen cells after treatment with Corynebacterium parvum.

Authors:  H Kirchner; H M Hirt; H Becker; K Munk
Journal:  Cell Immunol       Date:  1977-06-01       Impact factor: 4.868

4.  Antibody to Corynebacterium parvum in normal human and animal sera.

Authors:  G Wolberg; G S Duncan; C Adlam; J K Whisnant
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

5.  Production and properties of migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity.

Authors:  J S Youngner; S B Salvin
Journal:  J Immunol       Date:  1973-12       Impact factor: 5.422

6.  Interferon inhibits DNA synthesis induced in mouse lymphocyte suspensions by phytohaemagglutinin or by allogeneic cells.

Authors:  P Lindahl-Magnusson; P Leary; I Gresser
Journal:  Nat New Biol       Date:  1972-05-24

7.  In vitro inhibition of tumour cell growth and DNA synthesis by peritoneal and lung macrophages from mice injected with Corynebacterium parvum.

Authors:  M Olivotto; R Bomford
Journal:  Int J Cancer       Date:  1974-04-15       Impact factor: 7.396

Review 8.  Corynebacterium parvum as an immunotherapeutic anticancer agent.

Authors:  M T Scott
Journal:  Semin Oncol       Date:  1974-12       Impact factor: 4.929

9.  Protection against herpes simplex virus infection in mice by Corynebacterium parvum.

Authors:  H Kirchner; H M Hirt; K Munk
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

10.  Replication of herpes simplex virus in mouse spleen cell cultures stimulated by lipopolysaccharide.

Authors:  H Kirchner; H M Hirt; C Kleinicke; K Munk
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

View more
  5 in total

1.  Adjuvants et stimulants de l'immunité: propriétés immunorégulatrices du muramyl-dipeptide, des corynébactéries anaérobies et du diéthyldithiocarbamate de sodium.

Authors:  D Archambault; G Morin
Journal:  Can Vet J       Date:  1988-01       Impact factor: 1.008

2.  Interferons and bacterial infections.

Authors:  H Kirchner; W Digel; E Storch
Journal:  Klin Wochenschr       Date:  1982-07-15

3.  Deficient IFN alpha production in hairy cell leukemia.

Authors:  F Porzsolt; R Janik; G Heil; O Brudler; A Raghavachar; S Scholz; U Papendick; H Heimpel
Journal:  Blut       Date:  1986-03

4.  Characterization of interferons induced by bacteria and interferon-producing leukocytes in human peripheral blood.

Authors:  L Rönnblom; A Forsgren; G V Alm
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

5.  COVID-19 vaccine and boosted immunity: Nothing ad interim to do?

Authors:  Luca Roncati; Maria Vadalà; Veronica Corazzari; Beniamino Palmieri
Journal:  Vaccine       Date:  2020-10-09       Impact factor: 3.641

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.